147 related articles for article (PubMed ID: 38147960)
1. Fibroblast Subpopulations in Systemic Sclerosis: Functional Implications of Individual Subpopulations and Correlations with Clinical Features.
Zhu H; Luo H; Skaug B; Tabib T; Li YN; Tao Y; Matei AE; Lyons MA; Schett G; Lafyatis R; Assassi S; Distler JHW
J Invest Dermatol; 2024 Jun; 144(6):1251-1261.e13. PubMed ID: 38147960
[TBL] [Abstract][Full Text] [Related]
2. Myofibroblast transcriptome indicates SFRP2
Tabib T; Huang M; Morse N; Papazoglou A; Behera R; Jia M; Bulik M; Monier DE; Benos PV; Chen W; Domsic R; Lafyatis R
Nat Commun; 2021 Jul; 12(1):4384. PubMed ID: 34282151
[TBL] [Abstract][Full Text] [Related]
3. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta.
Farina G; Lemaire R; Pancari P; Bayle J; Widom RL; Lafyatis R
Ann Rheum Dis; 2009 Mar; 68(3):435-41. PubMed ID: 18408251
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
[TBL] [Abstract][Full Text] [Related]
6. β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis.
Beyer C; Schramm A; Akhmetshina A; Dees C; Kireva T; Gelse K; Sonnylal S; de Crombrugghe B; Taketo MM; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2012 May; 71(5):761-7. PubMed ID: 22328737
[TBL] [Abstract][Full Text] [Related]
7. Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.
Wu M; Pedroza M; Lafyatis R; George AT; Mayes MD; Assassi S; Tan FK; Brenner MB; Agarwal SK
Arthritis Rheumatol; 2014 Apr; 66(4):1010-21. PubMed ID: 24757152
[TBL] [Abstract][Full Text] [Related]
8. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
9. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.
Valenzi E; Bulik M; Tabib T; Morse C; Sembrat J; Trejo Bittar H; Rojas M; Lafyatis R
Ann Rheum Dis; 2019 Oct; 78(10):1379-1387. PubMed ID: 31405848
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
11. Single-Cell Transcriptome Analysis Identifies Subclusters with Inflammatory Fibroblast Responses in Localized Scleroderma.
Werner G; Sanyal A; Mirizio E; Hutchins T; Tabib T; Lafyatis R; Jacobe H; Torok KS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372943
[TBL] [Abstract][Full Text] [Related]
12. The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis.
Yasuoka H; Yamaguchi Y; Feghali-Bostwick CA
PLoS One; 2014; 9(2):e87754. PubMed ID: 24551065
[TBL] [Abstract][Full Text] [Related]
13. Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc.
Liang R; Kagwiria R; Zehender A; Dees C; Bergmann C; Ramming A; Krasowska D; Michalska-Jakubus M; Kreuter A; Kraner ME; Schett G; Distler JHW
Ann Rheum Dis; 2019 Sep; 78(9):1269-1273. PubMed ID: 31177096
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Aquaporin3 in Systemic Sclerosis Dermal Fibroblasts.
Yousefi B; Mahmoudi M; Sarafnejad A; Karimizadeh E; Farhadi E; Jamshidi AR; Kavosi H; Aslani S; Gharibdoost F
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):228-234. PubMed ID: 28732436
[TBL] [Abstract][Full Text] [Related]
15. Role of endothelin-1 in the skin fibrosis of systemic sclerosis.
Jing J; Dou TT; Yang JQ; Chen XB; Cao HL; Min M; Cai SQ; Zheng M; Man XY
Eur Cytokine Netw; 2015; 26(1):10-4. PubMed ID: 25990837
[TBL] [Abstract][Full Text] [Related]
16. Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis.
Bhattacharyya S; Sargent JL; Du P; Lin S; Tourtellotte WG; Takehara K; Whitfield ML; Varga J
PLoS One; 2011; 6(9):e23082. PubMed ID: 21931594
[TBL] [Abstract][Full Text] [Related]
17. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
[TBL] [Abstract][Full Text] [Related]
18. TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis.
Laurent P; Allard B; Manicki P; Jolivel V; Levionnois E; Jeljeli M; Henrot P; Izotte J; Leleu D; Groppi A; Seneschal J; Constans J; Chizzolini C; Richez C; Duffau P; Lazaro E; Forcade E; Schaeverbeke T; Pradeu T; Batteux F; Blanco P; Contin-Bordes C; Truchetet ME
Ann Rheum Dis; 2021 Dec; 80(12):1594-1603. PubMed ID: 34285051
[TBL] [Abstract][Full Text] [Related]
19. A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis.
Usategui A; Criado G; Izquierdo E; Del Rey MJ; Carreira PE; Ortiz P; Leonard WJ; Pablos JL
Ann Rheum Dis; 2013 Dec; 72(12):2018-23. PubMed ID: 23413283
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
